Top Markets
#1 Fabric Protocol Fabric Protocol +32.06%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.94%
#3 Tutorial Tutorial +31.67%
#4 Bitcoin Cash Bitcoin Cash +31.12%
#5 GALA GALA +30.99%
#6 Audiera Audiera +30.55%
#7 Zora Zora +26.33%
#8 GoPlus Security GoPlus Security +26.04%
#9 Arowana Arowana +25.32%
#10 Talus Network Talus Network +24.98%
Coin of the day
Fabric Protocol Fabric Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
Kedudukan dalam Saham #24450
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
Harga Saham
$0.78611575
Modal Pasaran
$60.45M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-12.06%
Negara
NO
Perdagangan Lytix Biopharma AS (LYTIX)

Kategori

Healthcare
Pendapatan untuk Lytix Biopharma AS (LYTIX)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Lytix Biopharma AS, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Lytix Biopharma AS dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH